Company Monitoring Page for BeiGene

latest headlines for company on cafepharma

Amgen wades deeper into Asia with full control of an Astellas Japanese JV
Fierce Pharma
Thu, 01/23/20 - 12:12 pm
Tags:
Amgen, Astellas, Japan, BeiGene, China
BeiGene lung cancer treatment meets main goal in late-stage study
Reuters
Tue, 01/21/20 - 11:53 am
Tags:
BeiGene, cancer, lung cancer, clinical trials, tislelizumab
Amgen to Sell Cancer Drugs in China Thanks to $2.7B Deal with BeiGene
Xtalks
Fri, 01/3/20 - 10:51 pm
Tags:
Amgen, BeiGene, oncology, China
Boehringer cleared to manufacture BeiGene’s cancer drug for Chinese market
Pharmaforum
Fri, 01/3/20 - 09:45 am
Tags:
Boehringer Ingelheim, China, BeiGene, drug manufacturing
3 Blockbuster Cancer Drug Launches to Watch in 2020
Motley Fool
Thu, 01/2/20 - 11:57 pm
Tags:
FDA, drug approvals, cancer, drug launches, AstraZeneca, Enhertu, Padcev, Seattle Genetics, BeiGene, Brukinsa
Corporate and regulatory developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:39 pm
Tags:
Astellas, M&A, Qiagen, AstraZeneca, Bausch Health, BeiGene, Celyad, Immunomedics, Merck, Merck KGaA, Ono Pharmaceutical, Pfizer, Pharming, Xyphos Biosciences
5 New Drug Approvals the FDA Gave Top Priority
Motley Fool
Sat, 11/30/19 - 11:22 pm
Tags:
FDA, drug approvals, Global Blood Therapeutics, Oxbryta, Alnylam, Givlaari, BeiGene, Brukinsa, Vertex Pharmaceuticals
FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
RAPS.org
Wed, 11/27/19 - 12:39 pm
Tags:
FDA, Vertex Pharmaceuticals, Trikafta, Novartis, Adakveo, Alnylam, Givlaari, BeiGene, Brukinsa, Global Blood Therapeutics, Oxbryta, drug approvals
China's BeiGene gets FDA approval for drug to treat rare form of lymphoma
Yahoo/Reuters
Thu, 11/14/19 - 07:27 pm
Tags:
BeiGene, China, FDA, Brukinsa, mantle cell lymphoma
Ahead of FDA decision on BTK drug, Amgen-partnered BeiGene scores China OK for PD-1
Endpoints
Wed, 11/13/19 - 10:03 am
Tags:
China, BeiGene, Amgen, tislelizumab, anti-PD-L1
Amgen pays $2.7bn to harness BeiGene’s China marketing muscle
Pharmaforum
Fri, 11/1/19 - 10:26 am
Tags:
Amgen, China, BeiGene
BeiGene's first U.S. NDA tests global development strategy
BioCentury
Sat, 08/24/19 - 11:06 am
Tags:
BeiGene, China, FDA, drug development, zanubrutinib
The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)
Yahoo/Motley Fool
Fri, 06/28/19 - 10:14 am
Tags:
Bristol-Myers Squibb, Celgene, M&A, BeiGene, tislelizumab, Otezla
As Bristol-Myers/Celgene tie up loose ends, BeiGene pockets $150M from PD-1 breakup
Endpoints
Mon, 06/17/19 - 10:06 am
Tags:
BeiGene, Bristol-Myers Squibb, Celgene, Opdivo
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/16/19 - 05:41 pm
Tags:
FDA, Merck, Arqule, Affimed, BeiGene, Epizyme, MorphoSys, Theravance, Allena Pharma, Akero Therapeutics, Atreca, Dermavant Sciences, Personalis, Prevail Therapeutics, Stoke Therapeutics, IPOs
Upcoming events – Crucial data on zanubrutinib and filgotinib approach
EP Vantage
Fri, 06/14/19 - 10:14 am
Tags:
BeiGene, Waldenström’s macroglobulinemia, zanubrutinib, Galapagos, filgotinib, CLE, Sjögren’s syndrome
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
Tags:
ADA, Merck, Keytruda, NGM Biopharmaceuticals, NGM313/MK-3655, Corbus Pharmaceuticals, Nektar, Galapagos, Kezar Life Sciences, Kura Oncology, Bluebird Bio, BeiGene, Global Blood Therapeutics, Blueprint Medicines, Regeneron, Arqule, Sunesis, Sutro BioPharma, Incyte, Geron, Forty Seven
Following key late-stage advances, BeiGene puts down $10M to get some discovery projects rolling at Ambrx
Endpoints
Wed, 03/6/19 - 10:10 am
Tags:
BeiGene, China, Ambrx
Smaller groups await Bristol-Myers Squelgene fallout
EP Vantage
Wed, 01/16/19 - 11:53 am
Tags:
M&A, Bristol-Myers Squibb, Celgene, Vividion Therapeutics, Evotec, Prothena, Anokion, Skyhawk Therapeutics, Dragonfly Therapeutics, BeiGene, Agios Pharmaceuticals, Jounce Therapeutics
In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica
Endpoints
Tue, 01/15/19 - 10:08 am
Tags:
China, FDA, Btk inhibitors, BeiGene, cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.